These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6389002)

  • 21. IgA nephropathy in Japan.
    Glassock RJ; Kurokawa K; Yoshida M; Sakai O; Okada M; Shigematsu H; Ohno J; Sakai H
    Am J Nephrol; 1985; 5(2):127-37. PubMed ID: 3993701
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunopathogenesis of experimental IgA nephropathy.
    Rifai A
    Springer Semin Immunopathol; 1994; 16(1):81-95. PubMed ID: 7997949
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunoglobulin A in alcoholic liver disease.
    van de Wiel A; Schuurman HJ; Kater L
    Contrib Nephrol; 1984; 40():276-82. PubMed ID: 6499457
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlation of paramesangial deposits and glomerular sclerosis and/or hyalinosis in patients with IgA nephropathy.
    Tomino Y; Sakai H; Basolo B; Aarons I; Clarkson AR
    Tokai J Exp Clin Med; 1986 Oct; 11(4):235-9. PubMed ID: 2441490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mesangial proliferative glomerulonephritis].
    Yamada A
    Nihon Rinsho; 2004 Oct; 62(10):1842-6. PubMed ID: 15500128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the antigen on experimental IgA nephropathy.
    Imai H; Chen A; Endoh M; Rifai A
    Semin Nephrol; 1987 Dec; 7(4):283-5. PubMed ID: 2451262
    [No Abstract]   [Full Text] [Related]  

  • 27. Exacerbating factors in patients with IgA nephropathy.
    Tomino Y; Sakai H
    Semin Nephrol; 1987 Dec; 7(4):315-7. PubMed ID: 2451264
    [No Abstract]   [Full Text] [Related]  

  • 28. [Secondary IgA-nephropathy in gastroenterological diseases].
    Szigeti N; Kovács T; Degrell P; Fábián G; Wittmann I; Nagy J
    Orv Hetil; 2007 Feb; 148(7):313-8. PubMed ID: 17344151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathologic features of membranous nephropathy coexisting with IgA nephropathy].
    Wang SX; Zou WZ; Yang L; Zhao MH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):171-4. PubMed ID: 17535683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?
    Floege J
    Am J Kidney Dis; 2011 Dec; 58(6):992-1004. PubMed ID: 21872377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emerging spectrum of IgA-mediated renal diseases: is there an IgA variant of Goodpasture's syndrome?
    Lee SM; Marks EA
    Am J Kidney Dis; 1999 Sep; 34(3):565-8. PubMed ID: 10469870
    [No Abstract]   [Full Text] [Related]  

  • 32. Nephroquiz 2: differential diagnoses of mesangial proliferative glomerulonephritis.
    Parvin M; Haghverdi F; Ahmadpoor P
    Iran J Kidney Dis; 2009 Jul; 3(3):172-3. PubMed ID: 19617668
    [No Abstract]   [Full Text] [Related]  

  • 33. Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice.
    Rops ALWMM; Jansen E; van der Schaaf A; Pieterse E; Rother N; Hofstra J; Dijkman HBPM; van de Logt AE; Wetzels J; van der Vlag J; van Spriel AB
    Kidney Int; 2018 Jun; 93(6):1356-1366. PubMed ID: 29551516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrarenal cytokines modulate the glomerular response to IgA immune complexes.
    Montinaro V; Hevey K; Aventaggiato L; Fadden K; Esparza A; Chen A; Finbloom DS; Rifai A
    Kidney Int; 1992 Aug; 42(2):341-53. PubMed ID: 1405317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enigmas in the pathogenesis of IgA nephropathy.
    van Es LA; van den Wall Bake AW; Stad RK; van den Dobbelsteen ME; Bogers MJ; Daha MR
    Contrib Nephrol; 1995; 111():169-75; discussion 175-6. PubMed ID: 7758338
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathogenesis of immunoglobulin A nephropathy.
    D'Amico G
    Curr Opin Nephrol Hypertens; 1998 May; 7(3):247-50. PubMed ID: 9617552
    [No Abstract]   [Full Text] [Related]  

  • 37. Nuclear factor kappa B activation in glomeruli of posttransplant IgA nephropathy using southwestern histochemistry.
    Hong SW; Jeong HJ; Kim YS; Kim SI; Choi KH; Lee HY; Han DS; Park K
    Transplant Proc; 2003 Feb; 35(1):179-80. PubMed ID: 12591356
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of fish oil and alpha-tocopherol in immunoglobulin A nephropathy in the rat.
    Kuemmerle NB; Chan W; Krieg RJ; Norkus EP; Trachtman H; Chan JC
    Pediatr Res; 1998 Jun; 43(6):791-7. PubMed ID: 9621989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy.
    Lamm ME; Emancipator SN; Robinson JK; Yamashita M; Fujioka H; Qiu J; Plaut AG
    Am J Pathol; 2008 Jan; 172(1):31-6. PubMed ID: 18165266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
    Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
    Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.